ALOI, MARINA

ALOI, MARINA  

Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti  

Mostra records
Risultati 1 - 20 di 85 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Vedolizumab for extraintestinal manifestations in pediatric inflammatory bowel disease: Results from the VedoKids study 2026 Marina Aloi + Article (author) -
Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn's disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient 2026 Aloi, Marina + Article (author) -
Exploring novel biomarkers in pediatric ulcerative colitis: The role of Lipocalin-2, MMP-9, and MMP-9/LCN-2 complex 2026 Aloi, Marina + Article (author) -
Impact of 5‐ASA discontinuation in children with ulcerative colitis on biologic therapy: A propensity score‐matched study 2026 Mancuso, GiuliaNorsa, LorenzoAloi, Marina + Article (author) -
Can liver biopsy be spared for the diagnosis of autoimmune hepatitis in selected children? A multicenter retrospective study 2026 Delle Cave, ValeriaAloi, Marina + Article (author) -
Reshaping study design for faster extrapolation‐based drug approval in pediatric inflammatory bowel diseases: An ESPGHAN–NASPGHAN position paper 2026 Aloi, Marina + Article (author) -
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study 2026 Aloi, MarinaCaprioli, FlavioPastorelli, Luca + Article (author) -
Intestinal Ultrasound Scan in Acute Severe Ulcerative Colitis in Children: A Multicenter Prospective Study on Behalf of the Porto Inflammatory Bowel Disease Working Group of European Society for Paediatric Gastroenterology Hepatology and Nutrition 2026 Aloi, Marina + Article (author) -
Management of pediatric inflammatory bowel diseases in limited-resource settings: A position paper from the Paediatric IBD Porto Group of ESPGHAN 2025 Aloi, Marina + Article (author) -
Management of paediatric ulcerative colitis, part 2: Acute severe colitis-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organization 2025 Aloi, MarinaGianolio, LauraNorsa, Lorenzo + Article (author) -
Management of paediatric ulcerative colitis, part 1: Ambulatory care-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation 2025 Aloi, MarinaGianolio, LauraNorsa, Lorenzo + Article (author) -
Effect of Overweight and Obesity on the Response to Anti-TNF Therapy and Disease Course in Children With IBD 2025 Aloi, MarinaGianolio, LauraNorsa, Lorenzo + Article (author) -
European Crohn's and Colitis Organisation consensus on dietary management of inflammatory bowel disease 2025 Aloi, Marina + Article (author) -
Prevalence and outcomes of arthritis in pediatric IBD: A multicenter study from the Italian Society of Pediatric Gastroenterology Hepatology and Nutrition 2025 Aloi, MarinaNorsa, Lorenzo + Article (author) -
Prevalence and trend of anemia in children with inflammatory bowel disease: A national register-based cohort study 2025 Norsa, LorenzoAloi, Marina + Article (author) -
Long‐term outcome of pediatric acute severe colitis: A prospective 5‐year follow‐up of the PRASCO trial 2025 Aloi, Marina + Article (author) -
Update on pediatric inflammatory bowel diseases epidemiology during SARS-CoV-2 outbreak:data from the Italian society of pediatric gastroenterology, epatology and nutrition registry 2025 Aloi, MarinaNorsa, Lorenzo + Article (author) -
Gene expression profile predicts response to antitumor necrosis factor in children with Crohn's disease: A Porto group biobank study, and a systematic review 2025 Norsa, LorenzoAloi, Marina + Article (author) -
Whole Food Diet Induces Remission in Children and Young Adults With Mild to Moderate Crohn's Disease and Is More Tolerable Than Exclusive Enteral Nutrition: A Randomized Controlled Trial 2025 Aloi, Marina + Article (author) -
Real-life durability and risk factors for biologic discontinuation in pediatric inflammatory bowel disease: results from the SIGENP IBD registry 2025 Ancona S.Norsa L.Penagini F.Aloi M.Giangreco M. + Article (author) -